Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07161635 · ClinicalTrials.gov registry record · NA
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
A NA study of Presbyopia and Aphakia, sponsored by Alcon Research.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 5
- Study locations
NCT07161635 is a NA study of Presbyopia and Aphakia that is actively recruiting participants, run by Alcon Research. The registered enrollment target is 120 participants, below the 267-participant average among 38 other Presbyopia trials with a reported enrollment target (55% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT07161635, a NA study of Presbyopia and Aphakia, is actively recruiting participants, sponsored by Alcon Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.
Conditions Studied
Interventions
- DEVICE Clareon PanOptix Pro/Pro Toric Trifocal IOL
- PROCEDURE Phacoemulsification
Study Locations (5)
California
- Wolstan & Goldberg Eye Associates - Torrance
Missouri
- Moyes Eye Center - Kansas City
South Carolina
- Carolina Eyecare Physicians LLC - Mt. Pleasant
Texas
- Houston Eye Associates - Houston
Utah
- The Eye Institute of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-10-14 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07161635
The ClinicalTrials.gov registry entry for NCT07161635 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 38 other Presbyopia trials with a reported enrollment target (55% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which Clareon PanOptix Pro/Pro Toric Trifocal IOL is the first listed.
NCT07161635 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Missouri, South Carolina.
Frequently Asked Questions
What is clinical trial NCT07161635 about?
NCT07161635 is a clinical study titled "Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs". The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.
What is the current status of trial NCT07161635?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-10-14. Estimated completion is 2026-10.
What conditions does trial NCT07161635 study?
This clinical trial studies the following conditions: Presbyopia, Aphakia.
What interventions are being tested in trial NCT07161635?
The interventions under investigation include: Clareon PanOptix Pro/Pro Toric Trifocal IOL (DEVICE), Phacoemulsification (PROCEDURE).
Who is sponsoring clinical trial NCT07161635?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07161635 being conducted?
This trial has 5 study locations across California, Missouri, South Carolina, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
-
A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.